Table of Contents

Executive Summary

1 Industry Overview of Fexofenadine

• 1.1 Definition of Fexofenadine
• 1.2 Fexofenadine Segment by Type
  • 1.2.1 Global Fexofenadine Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Purity:98%
  • 1.2.3 Purity:>98%
• 1.3 Fexofenadine Segment by Applications
  • 1.3.1 Global Fexofenadine Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hay Fever Treatment
  • 1.3.3 Urticaria Treatment
• 1.4 Global Fexofenadine Overall Market
  • 1.4.1 Global Fexofenadine Revenue (2014-2025)
  • 1.4.2 Global Fexofenadine Production (2014-2025)
  • 1.4.3 North America Fexofenadine Status and Prospect (2014-2025)
  • 1.4.4 Europe Fexofenadine Status and Prospect (2014-2025)
  • 1.4.5 China Fexofenadine Status and Prospect (2014-2025)
  • 1.4.6 Japan Fexofenadine Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Fexofenadine Status and Prospect (2014-2025)
  • 1.4.8 India Fexofenadine Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Fexofenadine
• 2.3 Manufacturing Process Analysis of Fexofenadine
• 2.4 Industry Chain Structure of Fexofenadine

3 Development and Manufacturing Plants Analysis of Fexofenadine

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Fexofenadine Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Fexofenadine
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Fexofenadine Production and Capacity Analysis
• 4.2 Fexofenadine Revenue Analysis
• 4.3 Fexofenadine Price Analysis
• 4.4 Market Concentration Degree

5 Fexofenadine Regional Market Analysis

• 5.1 Fexofenadine Production by Regions
  • 5.1.1 Global Fexofenadine Production by Regions
  • 5.1.2 Global Fexofenadine Revenue by Regions
• 5.2 Fexofenadine Consumption by Regions
• 5.3 North America Fexofenadine Market Analysis
  • 5.3.1 North America Fexofenadine Production
  • 5.3.2 North America Fexofenadine Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Fexofenadine Import and Export
• 5.4 Europe Fexofenadine Market Analysis
  • 5.4.1 Europe Fexofenadine Production
  • 5.4.2 Europe Fexofenadine Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Fexofenadine Import and Export
• 5.5 China Fexofenadine Market Analysis
  • 5.5.1 China Fexofenadine Production
  • 5.5.2 China Fexofenadine Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Fexofenadine Import and Export
• 5.6 Japan Fexofenadine Market Analysis
  • 5.6.1 Japan Fexofenadine Production
  • 5.6.2 Japan Fexofenadine Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Fexofenadine Import and Export
• 5.7 Southeast Asia Fexofenadine Market Analysis
  • 5.7.1 Southeast Asia Fexofenadine Production
  • 5.7.2 Southeast Asia Fexofenadine Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Fexofenadine Import and Export
• 5.8 India Fexofenadine Market Analysis
  • 5.8.1 India Fexofenadine Production
  • 5.8.2 India Fexofenadine Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Fexofenadine Import and Export

6 Fexofenadine Segment Market Analysis (by Type)

• 6.1 Global Fexofenadine Production by Type
• 6.2 Global Fexofenadine Revenue by Type
• 6.3 Fexofenadine Price by Type

7 Fexofenadine Segment Market Analysis (by Application)

• 7.1 Global Fexofenadine Consumption by Application
• 7.2 Global Fexofenadine Consumption Market Share by Application (2014-2019)

8 Fexofenadine Major Manufacturers Analysis

• 8.1 Viruj Pharma
  • 8.1.1 Viruj Pharma Fexofenadine Production Sites and Area Served
  • 8.1.2 Viruj Pharma Product Introduction, Application and Specification
  • 8.1.3 Viruj Pharma Fexofenadine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Cemex Pharma
  • 8.2.1 Cemex Pharma Fexofenadine Production Sites and Area Served
  • 8.2.2 Cemex Pharma Product Introduction, Application and Specification
  • 8.2.3 Cemex Pharma Fexofenadine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Smaart Pharmaceutticals
  • 8.3.1 Smaart Pharmaceutticals Fexofenadine Production Sites and Area Served
  • 8.3.2 Smaart Pharmaceutticals Product Introduction, Application and Specification
  • 8.3.3 Smaart Pharmaceutticals Fexofenadine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Titan Pharma
  • 8.4.1 Titan Pharma Fexofenadine Production Sites and Area Served
  • 8.4.2 Titan Pharma Product Introduction, Application and Specification
  • 8.4.3 Titan Pharma Fexofenadine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 AFCL
  • 8.5.1 AFCL Fexofenadine Production Sites and Area Served
  • 8.5.2 AFCL Product Introduction, Application and Specification
  • 8.5.3 AFCL Fexofenadine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Synkromax
  • 8.6.1 Synkromax Fexofenadine Production Sites and Area Served
  • 8.6.2 Synkromax Product Introduction, Application and Specification
  • 8.6.3 Synkromax Fexofenadine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Farmhispania
  • 8.7.1 Farmhispania Fexofenadine Production Sites and Area Served
  • 8.7.2 Farmhispania Product Introduction, Application and Specification
  • 8.7.3 Farmhispania Fexofenadine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Gen Pharma
  • 8.8.1 Gen Pharma Fexofenadine Production Sites and Area Served
  • 8.8.2 Gen Pharma Product Introduction, Application and Specification
  • 8.8.3 Gen Pharma Fexofenadine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Admiron Life Sciences Private Limited
  • 8.9.1 Admiron Life Sciences Private Limited Fexofenadine Production Sites and Area Served
  • 8.9.2 Admiron Life Sciences Private Limited Product Introduction, Application and Specification
  • 8.9.3 Admiron Life Sciences Private Limited Fexofenadine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 JRC
  • 8.10.1 JRC Fexofenadine Production Sites and Area Served
  • 8.10.2 JRC Product Introduction, Application and Specification
  • 8.10.3 JRC Fexofenadine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Archerchem
• 8.12 Sibram
• 8.13 Sumitomo Chemical
• 8.14 Panchsheel
• 8.15 CAMEO HEALTH CARE
• 8.16 CEPiA-Sanofi
• 8.17 Va Sudha Pharma Chem Limited
• 8.18 VPL Chemicals
• 8.19 Zhejiang Excel Pharmaceutical

9 Development Trend of Analysis of Fexofenadine Market

• 9.1 Global Fexofenadine Market Trend Analysis
  • 9.1.1 Global Fexofenadine Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Fexofenadine Regional Market Trend
  • 9.2.1 North America Fexofenadine Forecast 2019-2025
  • 9.2.2 Europe Fexofenadine Forecast 2019-2025
  • 9.2.3 China Fexofenadine Forecast 2019-2025
  • 9.2.4 Japan Fexofenadine Forecast 2019-2025
  • 9.2.5 Southeast Asia Fexofenadine Forecast 2019-2025
  • 9.2.6 India Fexofenadine Forecast 2019-2025
• 9.3 Fexofenadine Market Trend (Product Type)
• 9.4 Fexofenadine Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Fexofenadine Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

Fexofenadine is an allergic symptom in a drug against an antihistamine, such as for the treatment of hay fever and urticaria. Treatment, fexofenadine is a selective peripheral H1 receptor blocker

The global Fexofenadine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Fexofenadine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fexofenadine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Fexofenadine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Fexofenadine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Viruj Pharma
Cemex Pharma
Smaart Pharmaceutticals
Titan Pharma
AFCL
Synkromax
Farmhispania
Gen Pharma
Admiron Life Sciences Private Limited
JRC
Archerchem
Sibram
Sumitomo Chemical
Panchsheel
CAMEO HEALTH CARE
CEPiA-Sanofi
Va Sudha Pharma Chem Limited
VPL Chemicals
Zhejiang Excel Pharmaceutical

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Purity:98%
Purity:>98%

Segment by Application
Hay Fever Treatment
Urticaria Treatment